Vol 2005, No 63 (2005)

Table of Contents

Deal Trackers

Abatacept Abstract pdf
Business Review Editor

Research & Development

UCB and Imclone Strike Antibody Alliance Abstract pdf
Business Review Editor

Features

AstraZeneca and Early-Stage Deal Making Abstract pdf
Business Review Editor
Biogen Idec and PDL: Licensing Triumphs over Acquisition Abstract pdf
Business Review Editor
Baltic States Bring Biotech Expertise to Enlarged Europe Abstract pdf
Business Review Editor
Therapy Focus: Rheumatoid Arthritis Abstract pdf
Business Review Editor

Licensing

Sereno and Genmab Partner Again with a US$215 M Deal Abstract pdf
Business Review Editor

General

Adherex Transformed by Deal with GSK Abstract
Business Review Editor
Bavarian Nordic AS Abstract pdf
Business Review Editor

Mergers & Acquisitions

OSI to Buy Eyetech for US$935 M Abstract pdf
Business Review Editor
PLIVA’s Odyssey Pharmaceuticals Continues Divestment Spree Abstract pdf
Business Review Editor

Distribution & Marketing

Purdue Pharma to Market Labopharm’s Once-Daily Tramadol in the US Abstract pdf
Business Review Editor

Business Commentaries

Antipodean Innovation html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.